Dr. Annette Neele
This PhD student (DC6) will study new therapeutic targets to modulate inflammatory macrophage activation in atherosclerosis by investigating single cell RNA sequencing data for regulated signalling pathways, relevant upstream regulators and involved epigenetic enzymes.
The PhD student will be enrolled in the AMC Graduate School.
This PhD student will work on identifying new targets to modulate inflammatory macrophage activation in atherosclerosis by investigating single cell RNA sequencing data for regulated signalling pathways, relevant upstream regulators and involved epigenetic enzymes. The fellow will test top candidates using in vitro screening systems for functional consequences on macrophage activation by pharmacological (drugs) or genetics (CRISPR) interventions. Ultimately, validation experiments will need to be conducted to bring forward the therapeutic targets in in vivo mouse models for atherosclerosis.
COLLABORATORS AND SECONDMENTS IN THIS PHD PROJECT
ABOUT AMSTERDAM UNIVERSITY MEDICAL CENTER, LOCATION AMC
The Academic Medical Centre Amsterdam (AMC) is one of the foremost research institutions in the Netherlands, as well as one of its largest hospitals. Over 7,000 people work here to provide integrated patient care, fundamental and clinical scientific research, and teaching. The department of Medical Biochemistry participates in the MIRACLE network together with the department of Clinical Genetics where Doctoral Candidate position no. 8 will be hosted.
The highly translational research in the DC6 position will be performed in collaboration between these departments is particularly focused on macrophage activitation in the context of atherosclerosis, also known as a low-grade inflammatory disorder.
ABOUT THE SUPERVISORS
Prof. Menno de Winther and Dr. Annette Neele will be supervising the DC project at Amsterdam UMC.
Dr. Annette Neele